BofA/Merrill Lynch Downgrades Dr. Reddy's Laboratories (RDY) to Neutral
BofA/Merrill Lynch downgraded Dr. Reddy's Laboratories (NYSE: RDY) from Buy to Neutral following Q3 results.
For an analyst ratings summary and ratings history on Dr. Reddy's Laboratories click here. For more ratings news on Dr. Reddy's Laboratories click here.
Shares of Dr. Reddy's Laboratories closed at $34.82 yesterday, with a 52 week range of $27.28-$36.73.
For an analyst ratings summary and ratings history on Dr. Reddy's Laboratories click here. For more ratings news on Dr. Reddy's Laboratories click here.
Shares of Dr. Reddy's Laboratories closed at $34.82 yesterday, with a 52 week range of $27.28-$36.73.